Cavallin M - Search Results

1

Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia.

Damiani D, Tiribelli M, Geromin A, Cerno M, Sperotto A, Toffoletti E, Simeone E, Michelutti A, Cavallin M, Fanin R. Damiani D, et al. Among authors: cavallin m. Ann Hematol. 2012 Dec;91(12):1937-43. doi: 10.1007/s00277-012-1551-x. Epub 2012 Aug 15. Ann Hematol. 2012. PMID: 22893485

2

The prognostic value of P-glycoprotein (ABCB) and breast cancer resistance protein (ABCG2) in adults with de novo acute myeloid leukemia with normal karyotype.

Damiani D, Tiribelli M, Calistri E, Geromin A, Chiarvesio A, Michelutti A, Cavallin M, Fanin R. Damiani D, et al. Among authors: cavallin m. Haematologica. 2006 Jun;91(6):825-8. Epub 2006 May 16. Haematologica. 2006. PMID: 16704962

3

Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients.

Damiani D, Tiribelli M, Michelutti A, Geromin A, Cavallin M, Fabbro D, Pianta A, Malagola M, Damante G, Russo D, Fanin R. Damiani D, et al. Among authors: cavallin m. Leuk Res. 2010 Jul;34(7):942-5. doi: 10.1016/j.leukres.2010.01.008. Epub 2010 Jan 31. Leuk Res. 2010. PMID: 20122734

4

Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse.

Tiribelli M, Geromin A, Michelutti A, Cavallin M, Pianta A, Fabbro D, Russo D, Damante G, Fanin R, Damiani D. Tiribelli M, et al. Among authors: cavallin m. Cancer. 2011 May 15;117(10):2156-62. doi: 10.1002/cncr.25753. Epub 2010 Nov 29. Cancer. 2011. PMID: 21523728 Free article.

5

BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients.

Damiani D, Tiribelli M, Franzoni A, Michelutti A, Fabbro D, Cavallin M, Toffoletti E, Simeone E, Fanin R, Damante G. Damiani D, et al. Among authors: cavallin m. Am J Hematol. 2013 Oct;88(10):848-52. doi: 10.1002/ajh.23516. Epub 2013 Jul 23. Am J Hematol. 2013. PMID: 23760853 Free article. Clinical Trial.

6

ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome.

Damiani D, Tiribelli M, Geromin A, Michelutti A, Cavallin M, Sperotto A, Fanin R. Damiani D, et al. Among authors: cavallin m. Am J Hematol. 2015 Sep;90(9):784-9. doi: 10.1002/ajh.24084. Epub 2015 Jul 22. Am J Hematol. 2015. PMID: 26059733 Free article.

7

High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients.

Tiribelli M, Raspadori D, Geromin A, Cavallin M, Sirianni S, Simeone E, Bocchia M, Fanin R, Damiani D. Tiribelli M, et al. Among authors: cavallin m. Leuk Res. 2017 Jul;58:31-38. doi: 10.1016/j.leukres.2017.04.001. Epub 2017 Apr 4. Leuk Res. 2017. PMID: 28407515

8

Impact of Concomitant Aberrant CD200 and BCL2 Overexpression on Outcome of Acute Myeloid Leukemia: A Cohort Study from a Single Center.

Tiribelli M, Michelutti A, Cavallin M, Di Giusto S, Fanin R, Damiani D. Tiribelli M, et al. Among authors: cavallin m. Turk J Haematol. 2021 Jun 1;38(2):119-125. doi: 10.4274/tjh.galenos.2021.2020.0728. Epub 2021 Feb 18. Turk J Haematol. 2021. PMID: 33596632 Free PMC article.

9

ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML.

Tiribelli M, Geromin A, Cavallin M, Di Giusto S, Simeone E, Fanin R, Damiani D. Tiribelli M, et al. Among authors: cavallin m. Eur J Haematol. 2017 Sep;99(3):269-274. doi: 10.1111/ejh.12915. Epub 2017 Jul 20. Eur J Haematol. 2017. PMID: 28618016

10

Cytomegalovirus Prophylaxis versus Pre-emptive Strategy: Different CD4⁺ and CD8⁺ T Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.

Sperotto A, Candoni A, Gottardi M, Facchin G, Stella R, De Marchi R, Michelutti A, Cavallin M, Rosignoli C, Patriarca F, Fanin R. Sperotto A, et al. Among authors: cavallin m. Transplant Cell Ther. 2021 Jun;27(6):518.e1-518.e4. doi: 10.1016/j.jtct.2021.03.003. Epub 2021 Mar 5. Transplant Cell Ther. 2021. PMID: 33812803 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters